249
Participants
Start Date
September 30, 2020
Primary Completion Date
March 31, 2023
Study Completion Date
July 13, 2023
Pegcetacoplan (APL-2)
Complement (C3) Inhibitor
Placebo
Sterile solution of equal volume to active arm
Brain and Mind Centre, Camperdown
Central Coast Neurosciences Research, Erina
Nueor-Immunology Clinical Researh Education and Support Service (N-CRESS), Austin Health, Heidelberg
Royal Brisbane and Women's Hospital, Herston
Gold Coast University Hospital, Southport
CHU de Nice Hôpital Pasteur, Nice
Hospital for Special Surgery, New York
Azienda Ospedaliera Universitaria di Torino - Città della Salute e della Scienza di Torino, Torino
Universitätsmedizin Rostock, Klinik und Poliklinik für Neurologie, Rostock
Ospedale Niguarda - Nemo Clinical Center - Fondazione Serena Onlus, Milan
Johns Hopkins, Baltimore
Medizinische Hochschule Hannover Klinik für Neurologie, Hanover
Augusta University, Augusta
Hopital Pellegrin, Bordeaux
University of South Florida, Tampa
Ospedale Civile S. Agostino Estense di Modena, Azienda Ospedaliero Universitaria di Modena, Modena
Hospital Universitari I Politecnic La Fe, Valencia
Indiana University, Indianapolis
The Berman Center, Minneapolis
Hôpital Roger Salengro, Lille
SI Institute of Neurology, Psychiatry and Narcology of NAMSU, Kharkiv
CHU Gabriel Montpied, Clermont-Ferrand
Centre of Reconstructive and Restorative Medicine (University Clinic) Odessa National Medical University, Odesa
Zaporizhzhya Regional Clinical Hospital, Zaporizhzhya
Hôpital Neurologique Pierre Wertheimer, Bron
Austin Neuromuscular Center, Austin
University of Colorado, Aurora
CHU de Limoges Dupuytren 1, Limoges
University of Ulm, Ulm
Cedars-Sinai Medical Center, Los Angeles
"AOUP P. Giaccone", Palermo
University of Vermont Medical Center, Burlington
AZ Sint-Lucas & Volkskliniek, Ghent
Universitaire Ziekenhuizen Leuven (UZ Leuven), Leuven
Vseobecna fakultni nemocnice v Praze, Prague
FORBELI s.r.o., Prague
Charité - Universitätsmedizin Berlin, Berlin
Universitätsklinikum Jena, Jena
Beaumont Hospital, Dublin
National Hospital Organization Higashinagoya National Hospital, Aichi
National Hospital Organization Omuta National Hospital, Fukuoka
National Hospital Organization Asahikawa Medical Center, Hokkaido
National Hospital Organization Hyogo-Chuo National Hospital, Hyōgo
National Hospital Organization Iou National Hospital, Ishikawa
National Hospital Organization Matsumoto Medical Center, Matsumoto
Niigata National Hospital National Hospital Organization, Niigata
National Hospital Organization Okinawa National Hospital, Okinawa
National Hospital Organization Higashisaitama National Hospital, Saitama
Shizuoka Institute of Epilepsy and Neurological Disorders, Shizuoka
Juntendo University Hospital, Tokyo
Tokyo Medical University Hospital, Tokyo
University Medical Center Utrecht, Utrecht
Uniwersytecki Szpital Kliniczny w Olsztynie Klinika Neurologii, Olsztyn
Centrum Medyczne NeuroProtect, Warsaw
City Clinic Sp. z o.o., Warsaw
Hospital Universitari Vall d'Hebron, Barcelona
Bellvitge University Hospital, Barcelona
University Hospitals Sussex NHS Foundation Trust, Brighton
Maurice Wohl Clinical Neuroscience Institute, King's College London, London
St George's University Hospitals NHS Foundation Trust, London
Lead Sponsor
Apellis Pharmaceuticals, Inc.
INDUSTRY